Nuclear medicine and RIS/PACS vendor ADAC Laboratories has brought some new faces to its management team. James Haisler has been named COO of the vendor’s Dallas-based healthcare information systems division. Haisler most recently served as
Nuclear medicine and RIS/PACS vendor ADAC Laboratories has brought some new faces to its management team. James Haisler has been named COO of the vendors Dallas-based healthcare information systems division. Haisler most recently served as president of the diagnostic imaging division of Phymatrix, and has also served as president and COO of Dornier Medical Systems. PACS veteran Kevin Flynn has been tapped as vice president of sales at ADAC HCIS. Flynn previously served as vice president of sales for Dome Imaging Systems, and prior to that was national sales manager for the clinical networking division of Siemens Medical Systems.
In other ADAC news, the Milpitas, CA-based firm reported that it has received orders for a record 10 C-PET units in its fiscal first quarter (end-January). In fiscal 1999, ADAC had been booking sales of three to five units per quarter. Among the new customers are Barnes Jewish Hospital in St. Louis, and the San Raffaele Hospital and Research Center in Milan, Italy.
ADAC also announced that it would settle the consolidated class action lawsuit pending against the firm. Under the agreement-in-principle, ADAC would pay the plaintiff class $20 million in full settlement of its claims.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.